期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

高龄急性心肌梗死患者直接PCI疗效及安全性研究 被引量：5

原文传递
导出
摘要 年龄是冠心病发病的绝对危险因素[1].随着我国步入老龄化社会,高龄冠心病和急性心肌梗死发病率呈现上升趋势.直接经皮冠状动脉介入治疗（percutaneous coronary intervention,PCI）较溶栓能更有效开通梗死相关血管,改善预后,是急性ST段抬高性心肌梗死（ST segment elevation myocardial infarction,STEMI）患者首选的再灌注治疗方案[2].然而许多大型随机临床研究未入选高龄患者,目前关于高龄STEMI患者直接PCI疗效及安全性尚存争议[3-4].本研究通过前瞻性观察比较不同年龄段STEMI患者直接PCI手术成功率、并发症以及主要心血管不良事件（major adverse cardiac event,MACE）,探讨高龄STEMI患者直接PCI的疗效和安全性.
作者 胡宪清 傅慎文 唐彪 钟鸣 杨依萍 毛燕艳
机构地区 金华市中心医院心血管一科
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2015年第3期277-280,共4页 Chinese Journal of Emergency Medicine
关键词 心肌梗死患者 直接PCI 急性心肌梗死 安全性 疗效 直接经皮冠状动脉介入治疗 急性ST段抬高性心肌梗死 主要心血管不良事件
分类号 R542.22 [医药卫生—心血管疾病]
  • 相关文献

参考文献8

二级参考文献52

  • 1曾侃.主动脉内气囊反搏术48例临床分析[J].中华外科杂志,1995,33(8):494-496. 被引量：6
  • 2急性心肌梗塞溶栓疗法参考方案（1996年7月修订）[J].中华心血管病杂志,1996,24(5):328-329. 被引量：1321
  • 3Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量：43
  • 4de Boer MJ,Ottervanger JP, van't Hof AW, et al. Reperfusion therapy in elderly patients with acute myocardial infarction: arandomized comparison of primary angioplasty and thrombolytic therapy. J Am Coil Cardiol,2002,39: 1723-1728.
  • 5Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytie therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet ,2003,361 : 13-20.
  • 6Boersma Eand Primary Coronary Angioplasty vs. Thrombolysis Does time matter? A pooled analysis of clinical trials comparing primary percutaneous coronary intervention and in-hospital fibfinolysis in acute myocardial infarction patients. Eur Heart J,2006,27: 779-788.
  • 7Rosengren A,Spetz CL, K~stner M, et al. Sex differences in survival after myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register. Eur Heart J, 2001,22 : 314-322.
  • 8Mehta RH, Granger CB, Alexander KP, et al. Reperfusion strategies for acute myocardial infarction in the elderly. J Am Coil Cardiol, 2005,45:471-478.
  • 9Devlin G, Gore JM, Elliott J, et al. GRACE Investigators. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST elevation acute coronary syndrome : The Global Registry of Acute Coronary Events. Eur Heart J, 2008,29 : 1275-1282.
  • 10Ogawa H, Kojima S. Modern state of acute myocardial infarction in the interventional era: observational case-control study- Japanese acute coronary syndrome study (JACSS). J Cardiol, 2009,54 : 1-9.

共引文献2037

同被引文献34

  • 1Kolh P, Windeeker S, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) [J]. Eur J Cardiothorac Surg, 2014, 46 (4): 517- 592.
  • 2Gagliardi AC, Miname MH, Santos RD. Uric acid: A marker ot increased cardiovascular risk [ J]. Atherosclerosis, 2009, 202 (1): 11-17.
  • 3Trkulja V, Car S. On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematie review and meta- analysis of prognostic studies [J]. Croat MedJ, 2012, 53 (2): 162-172.
  • 4Kaya MG, Uyarel H, Akpek M, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention [J]. Am J Cardiol, 2012, 109 (4) : 486-491.
  • 5Hamburger M, Baraf HS, Adamson TC 3rd, et al. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia [J]. Postgrad Med, 2011, 123 (6 Suppl 1) : 3- 36.
  • 6Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [ J]. Am J Cardiol, 1983, 51 (3) : 606-607.
  • 7Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and coronary heart disease: A systematic reciew and meta-analysis [J]. Arthritis Care Res (Hoboken), 2010, 62 (2): 170- 180.
  • 8Ehsan Qureshi A, Hameed S, Noeman A. Relationship of serum uric acid level and angiographie severity of coronary artery disease in male patients with acute coronary syndrome [ J ]. Pak J Med Sei, 2013, 29 (5): 1137-1141.
  • 9Kanbay M, S6nchez-Lozada LG, Franco M, et al. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin [ J ]. Nephrol Dial Transplant, 2011, 26 (2) : 430-437.
  • 10Zapolski T, Wacifaski P, Kondracki B, et al. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease [J]. Kardiol Pol, 2011, 69 (4): 319- 326.

引证文献5

二级引证文献20

中华急诊医学杂志
2015年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部